Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Annals of Behavioral Medicine
Erschienen in: Annals of Behavioral Medicine 1/2008

01.02.2008 | Original Article

Benefit Finding in Response to BRCA1/2 Testing

verfasst von: Carissa A. Low, M.A., Julienne E. Bower, Ph.D., Lorna Kwan, M.P.H., Joyce Seldon, M.S.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Undergoing genetic testing for BRCA1/2 mutations may be accompanied by elevated worry and distress, but the potential for the experience to catalyze positive psychological and life changes has not been studied.

Purpose

This study was designed to examine the relationship between mutation carrier status, personal cancer history, and the potential positive impact of genetic testing (i.e., benefit finding). We also tested two predictors of benefit finding (BF) derived from the theoretical and empirical literature on positive outcomes of stress: impact of the experience and approach-oriented coping.

Methods

Women undergoing genetic testing for BRCA1/2 mutations (n = 108) completed questionnaires assessing test-related distress, approach-oriented coping, and BF after receipt of test results. BRCA1/2 status was determined from genetic test results and personal cancer history from interviews conducted with study participants before testing.

Results

Reports of BF in this sample were highly variable, as some women did not perceive the testing experience as having any noticeable effect on their lives, whereas others reported positive changes similar to those observed in cancer patients (e.g., significantly improved relationships, greater appreciation for life). Contrary to hypotheses, women who tested positive for BRCA1/2 did not report higher levels of BF in response to genetic testing than those who tested negative. However, BF scores were elevated among mutation carriers who had a previous cancer diagnosis. As predicted, test-related distress and approach-oriented coping were also positively associated with BF, and approach-oriented coping mediated the relationship between carrier status × cancer history and BF.

Conclusions

Findings suggest that positive life changes can occur among women who test positive for BRCA1/2 mutations, particularly cancer survivors.
Fußnoten
1
Results of mediation analyses were similar when the interaction term was coded as in primary regression analyses, comparing affected carriers and non-affected non-carriers (dummy code = 1) to non-affected carriers and affected non-carriers (dummy code = 0).
 
Literatur
1.
Tedeschi RG, Calhoun LG. The posttraumatic growth inventory: Measuring the positive legacy of trauma. J Trauma Stress. 1996; 9: 455–471.PubMedCrossRef
2.
Affleck G, Tennen H, Croog S, Levine S. Causal attributions, perceived benefits, and morbidity after a heart attack: An eight-year study. J Consult Clin Psychol. 1987; 55: 29–35.PubMedCrossRef
3.
Bower JE, Kemeny ME, Taylor SE, Fahey JL. Cognitive processing, discovery of meaning, CD-4 decline, and AIDS-related mortality among bereaved HIV seropositive gay men. J Consult Clin Psychol. 1998; 66: 979–986.PubMedCrossRef
4.
Frazier P, Conlon A, Glaser T. Positive and negative life changes following sexual assault. J Consult Clin Psychol. 2001; 69: 1048–1055.PubMedCrossRef
5.
Milam JE. Posttraumatic growth among HIV/AIDS patients. J Appl Soc Psychol. 2004; 34: 2353–2376.CrossRef
6.
Updegraff JA, Taylor SE, Kemeny ME, Wyatt GE. Positive and negative effects of HIV-infection in women with low socioeconomic resources. Pers Soc Psychol Bull. 2002; 28: 382–394.CrossRef
7.
Taylor SE. Adjustment to threatening events: A theory of cognitive adaptation. Am Psychol. 1983; 38: 1161–1173.CrossRef
8.
Tedeschi RG, Calhoun LG. Posttraumatic growth: Conceptual foundations and empirical evidence. Psychol Inq. 2004; 15: 1–18.CrossRef
9.
Bower JE, Meyerowitz BE, Desmond KA, et al. Perceptions of positive meaning and vulnerability following breast cancer: Predictors and outcomes among long-term breast cancer survivors. Ann Behav Med. 2005; 29: 236–245.PubMedCrossRef
10.
Carver CS, Antoni MH. Finding benefit in breast cancer during the year after diagnosis predicts better adjustment 5 to 8 years after diagnosis. Health Psychol. 2004; 23: 595–598.PubMedCrossRef
11.
Cordova MJ, Cunningham LLC, Carlson CR, Andrykowski MA. Posttraumatic growth following breast cancer: A controlled comparison study. Health Psychol. 2001; 20: 176–185.PubMedCrossRef
12.
Sears SR, Stanton AL, Danoff-Burg S. The yellow brick road and the emerald city: Benefit finding, positive reappraisal coping, and posttraumatic growth in women with early-stage breast cancer. Health Psychol. 2003; 22: 487–497.PubMedCrossRef
13.
Tomich PL, Helgeson VS. Is finding something good in the bad always good? Benefit finding among women with breast cancer. Health Psychol. 2004; 23: 16–23.PubMedCrossRef
14.
Stanton AL, Bower JE, Low CA. Posttraumatic growth after cancer. In: Calhoun LG, Tedeschi RG, eds. Handbook of posttraumatic growth: Research and practice. Mahwah, NJ: Erlbaum; 2006: 138–75.
15.
Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers: Breast Cancer Linkage Consortium. Am J Hum Genet. 1995; 56: 265–271.PubMed
16.
King MC, Marks JH, Mandell JB, the New York Breast Cancer Study Group. Breast and ovarian risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003; 302: 643–646.PubMedCrossRef
17.
Hamann HA, Somers TJ, Smith AW, Inslicht SS, Baum A. Posttraumatic stress associated with cancer history and BRCA1/2 genetic testing. Psychosom Med. 2005; 67: 766–772.PubMedCrossRef
18.
Lerman C, Narod S, Schulman K, et al. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. JAMA. 1996; 275: 1885–1892.PubMedCrossRef
19.
Tercyak KP, Lerman C, Peshkin BN, et al. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Health Psychol. 2001; 20: 217–222.PubMedCrossRef
20.
Croyle RT, Smith KR, Botkin JR, Baty B Nash J. Psychological responses to BRCA1 mutation testing: Preliminary findings. Health Psychol. 1997; 16: 63–72.PubMedCrossRef
21.
Bonadona V, Saltel P, Desseigne F, et al. Cancer patients who experienced diagnostic genetic testing for cancer susceptibility: Reactions and behavior after the disclosure of a positive test result. Cancer Epidemiol Biomark Prev. 2002; 11: 97–104.
22.
Lim J, Macluran M, Price M, et al. Short- and long-term impact of receiving genetic mutation results in women at increased risk for hereditary breast cancer. J Genet Couns. 2004; 13: 115–133.PubMedCrossRef
23.
Schwartz MD, Peshkin BN, Hughes C, et al. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol. 2002; 20: 514–520.PubMedCrossRef
24.
Bish A, Sutton S, Jacobs C, et al. Changes in psychological distress after cancer genetic counseling: A comparison of affected and unaffected women. Br J Cancer. 2002; 86: 43–50.PubMedCrossRef
25.
Hallowell N, Foster C, Eeles R, Ardern-Jones A, Watson M. Accommodating risk: Responses to BRCA1/2 genetic testing of women who have had cancer. Soc Sci Med. 2004; 59: 553–565.PubMedCrossRef
26.
Janoff-Bulman R. Shattered assumptions: towards a new psychology of trauma. New York: Free Press; 2004.
27.
Andrykowski MA, Curran SL, Studts JL, et al. Psychosocial adjustment and quality of life in women with breast cancer and benign breast problems: A controlled comparison. J Clin Epidemiol. 1996; 49: 827–834.PubMedCrossRef
28.
Fromm K, Andrykowski MA, Hunt J. Positive and negative psychosocial sequelae of bone marrow transplantation: Implications for quality of life assessment. J Behav Med. 1996; 19: 221–240.PubMedCrossRef
29.
Lechner SC, Zakowski SG, Antoni MH, et al. Do sociodemographic and disease-related variables influence benefit finding in cancer patients? Psycho-oncology. 2003; 12: 491–499.PubMedCrossRef
30.
Oh S, Heflin L, Meyerowitz BE, et al. Quality of life of breast cancer survivors after a recurrence: A follow-up study. Breast Cancer Res Treat. 2004; 87: 45–57.PubMedCrossRef
31.
Urcuyo KR, Boyers AE, Carver CS, Antoni MH. Finding benefit in breast cancer: Relations with personality, coping, and concurrent well-being. Psychol Health. 2005; 20: 175–192.CrossRef
32.
Antoni MH, Lehman JM, Kilbourn KM, et al. Cognitive-behavioral stress-management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer. Health Psychol. 2001; 20: 20–32.PubMedCrossRef
33.
Bellizzi KM, Blank TO. Predicting posttraumatic growth in breast cancer survivors. Health Psychol. 2006; 25: 47–56.PubMedCrossRef
34.
Weinrib AZ, Rothrock NE, Johnsen EL, Lutgendorf SK. The assessment and validity of stress-related growth in a community-based sample. J Consult Clin Psychol. 2006; 74: 851–858.PubMedCrossRef
35.
Horowitz M, Wilner N, Alvarez W. Impact of events scale: a measure of subjective stress. Psychosom Med. 1979; 41: 209–218.PubMed
36.
Weiss DS, Marmar CR. The impact of event scale-revised. In: Wilson JP, Keane TM, eds. Assessing Psychological Trauma and PTSD. New York: Guilford Press; 1997.
37.
Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: A theoretically based approach. J Pers SocPsychol. 1989; 56: 267–283.CrossRef
38.
Stanton AL, Kirk SB, Cameron CL, Danoff-Burg S. Coping through emotional approach: Scale construction and validation. J Pers SocPsychol. 2000; 78: 1150–1169.CrossRef
39.
Widows MR, Jacobsen PB, Booth-Jones M, Fields KK. Predictors of posttraumatic growth following bone marrow transplantation for cancer. Health Psychol. 2005; 24: 266–273.PubMedCrossRef
40.
van Dijk S, Timmermans DR, Meijers-Heijboer H, et al. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. J Clin Oncol. 2006; 24: 3672–3677.PubMedCrossRef
41.
Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers SocPsychol. 1986; 51: 1173–1182.CrossRef
42.
Yehuda R, Flory JD, Southwick S, Charney DS. Developing an agenda for translational studies of resilience and vulnerability following trauma exposure. Ann N Y Acad Sci. 2006; 1071: 379–396.PubMedCrossRef
43.
Baum A, Friedman AL, Zakowski SG. Stress and genetic testing for disease risk. Health Psychol. 1997; 16: 8–19.PubMedCrossRef
44.
McFarland C, Alvaro C. The impact of motivation on temporal comparisons: Coping with traumatic events by perceiving personal growth. J Pers SocPsychol. 2000; 79: 327–343.CrossRef
Metadaten
Titel
Benefit Finding in Response to BRCA1/2 Testing
verfasst von
Carissa A. Low, M.A.
Julienne E. Bower, Ph.D.
Lorna Kwan, M.P.H.
Joyce Seldon, M.S.
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Annals of Behavioral Medicine / Ausgabe 1/2008
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-007-9004-9

Weitere Artikel der Ausgabe 1/2008

Annals of Behavioral Medicine 1/2008 Zur Ausgabe

Original Article

Cognitive–Behavioral Stress Management Interventions for Persons Living with HIV: A Review and Critique of the Literature

Original Article

Perceived Stress is Associated with Impaired T-Cell Response to HPV16 in Women with Cervical Dysplasia

Original Article

Social Support and Self-Care of Patients with Heart Failure

Presidential Address

The Importance of Context in Understanding Behavior and Promoting Health

Rapid Communication

The Effects of Race-related Stress on Cortisol Reactivity in the Laboratory: Implications of the Duke Lacrosse Scandal

Original Article

Preferences for a Patient-Centered Role Orientation: Association with Patient-Information-Seeking Behavior and Clinical Markers of Health

Neu in den Fachgebieten Neurologie und Psychiatrie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Bildnachweise